Fortress Biotech Inc FBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.79quote price arrow down-0.02 (-1.10%)
Volume
108,315
52 week range
1.24 - 12.00
Loading...
  • Open1.79
  • Day High1.80
  • Day Low1.76
  • Prev Close1.81
  • 52 Week High12.00
  • 52 Week High Date04/24/23
  • 52 Week Low1.24
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap34.43M
  • Shares Out19.23M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-40.53

KEY STATS

  • Open1.79
  • Day High1.80
  • Day Low1.76
  • Prev Close1.81
  • 52 Week High12.00
  • 52 Week High Date04/24/23
  • 52 Week Low1.24
  • 52 Week Low Date11/10/23
  • Market Cap34.43M
  • Shares Out19.23M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-40.53

RATIOS/PROFITABILITY

  • EPS (TTM)-53.18
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-0.27
  • EBITDA (TTM)-133.025M
  • ROE (TTM)-213.73%
  • Revenue (TTM)84.513M
  • Gross Margin (TTM)68.45%
  • Net Margin (TTM)-182.40%
  • Debt To Equity (MRQ)283.25%

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fortress Biotech Inc

 

Profile

MORE
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six market areas, including oncology, rare diseases...
Lindsay Rosenwald M.D.
Executive Chairman of the Board, President, Chief Executive Officer
David Jin
Chief Financial Officer, Corporate Secretary
Address
1111 KANE CONCOURSE, SUITE 301
Bay Harbor Islands, FL
33154
United States

Top Peers

SYMBOLLASTCHG%CHG
HLTH
Cue Health Inc
0.146-0.004-2.6667%
PSNL
Personalis Inc
1.30-0.08-5.80%
RDHL
Redhill Biopharma Ltd
0.4199-0.0079-1.8434%
CDTX
Cidara Therapeutics Inc
12.29+2.04+19.90%
ENZ
Enzo Biochem Inc
1.06-0.03-2.75%